Surface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC (Review)

  • Authors:
    • Lige Qiu
    • Hailiang Li
    • Sirui Fu
    • Xiaofang Chen
    • Ligong Lu
  • View Affiliations

  • Published online on: December 8, 2017     https://doi.org/10.3892/ol.2017.7568
  • Pages:2039-2048
Metrics: HTML 0 views | PDF 0 views     Cited By: 0 citations

Abstract

Liver cancer stem cells (LCSCs) have important roles in the occurrence, development, recurrence, therapy resistance and metastasis of hepatocellular carcinoma (HCC). Therefore, intensive studies are undergoing to identify the mechanisms by which LCSCs contribute to HCC invasion and metastasis, and to design more efficient treatments for this disease. With continuous efforts in LCSC research over the years, therapies targeting LCSCs are thought to have great potential for the clinical treatment and prognosis of liver cancer. Novel LCSC surface markers are continuously discovered and several have been used in targeted therapies to reduce HCC recurrence, metastasis, and drug resistance following tumor resection. The present review describes the surface markers characterizing LCSCs and the recent progress in therapies targeting these markers, including antibodies and polypeptides.

Related Articles

Journal Cover

February 2018
Volume 15 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

2016 Impact Factor: 1.39
Ranked #68/217 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Qiu, L., Li, H., Fu, S., Chen, X., & Lu, L. (2018). Surface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC (Review). Oncology Letters, 15, 2039-2048. https://doi.org/10.3892/ol.2017.7568
MLA
Qiu, L., Li, H., Fu, S., Chen, X., Lu, L."Surface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC (Review)". Oncology Letters 15.2 (2018): 2039-2048.
Chicago
Qiu, L., Li, H., Fu, S., Chen, X., Lu, L."Surface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC (Review)". Oncology Letters 15, no. 2 (2018): 2039-2048. https://doi.org/10.3892/ol.2017.7568